Status:
TERMINATED
Beta Blockade in Critical Injury
Lead Sponsor:
Denver Health and Hospital Authority
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Trauma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Critically injured patients endure a period of hypermetabolism/catabolism after being resuscitated. The metabolic cost of this may be measured in loss of lean body mass, poor wound healing, susceptibi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- ISS\>25, stable at 48 hours after injury
- Fully resuscitated
- Ventilated
- Exclusion Criteria Include:
- Intracranial hypertension requiring active treatment
- Hypotension/Pressors
- Already on beta blocker for a standard indication
Exclusion
Key Trial Info
Start Date :
February 15 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00356187
Start Date
February 15 2006
End Date
January 31 2009
Last Update
March 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Health Medical Center
Denver, Colorado, United States, 80204